BL&H Co Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BL&H Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014049
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-drug eluting beads, Lung Flute, OTC products, and ETC products. It provides products such as metoject, microshield, microshield antimicrobial hand gel, mutaflor cap, mutaflor sus, orfadin cap., sweatrol pad solution, trisenox inj. and others. BL&H’s products are used for the treatment of acute external otitis and rheumatoid arthritis; prevention of arteriosclerosis; and diagnosis of hereditary tyrosinemia type 1. The company has its presence in the US and Korea. BL&H is headquartered in Seoul, South Korea.

BL&H Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BL&H Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BL&H Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Theratechnologies Enters into Commercialization Agreement with BL&H 11
Swedish Orphan Enters Into Co-Marketing Agreement With BL&H 12
Licensing Agreements 13
BL&H Enters into Licensing Agreement with Race Oncology 13
BL&H Enter into Licensing Agreement with MDNA Life Sciences 14
BL&H Enters into Licensing Agreement with Telesta Therapeutics 15
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 16
Equity Offering 17
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 17
BL&H Co Ltd – Key Competitors 18
BL&H Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
BL&H Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BL&H Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BL&H Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
BL&H Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
BL&H Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Theratechnologies Enters into Commercialization Agreement with BL&H 11
Swedish Orphan Enters Into Co-Marketing Agreement With BL&H 12
BL&H Enters into Licensing Agreement with Race Oncology 13
BL&H Enter into Licensing Agreement with MDNA Life Sciences 14
BL&H Enters into Licensing Agreement with Telesta Therapeutics 15
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 16
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 17
BL&H Co Ltd, Key Competitors 18
BL&H Co Ltd, Other Locations 19

★海外企業調査レポート[BL&H Co Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • PharmaEngine Inc (4162):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaEngine Inc (PharmaEngine) is a biopharmaceutical company that discovers and develops cancer treatment drugs and related medicinal products. The company develops drugs for the treatment of cancer and Asian prevalent diseases. Its products include Onivyde a liposome encapsulation of irin …
  • Inspire Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Inspire Medical Systems Inc (Inspire) is a medical device company that manufactures and markets healthcare implants. The company provides implanted neurostimulation device. Its product is used for treatment of obstructive sleep apnea. Inspire uses neurostimulation technologies. The company’s …
  • Emerald Health Therapeutics Inc (EMH):製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis. The company extracts and markets dried cannabis, and cannabis oils and capsules. It offers cannabinoid medicines, which are present in an unparalleled opportu …
  • Dartmouth College:製薬・医療:M&Aディール及び事業提携情報
    Summary Dartmouth College (Dartmouth) is an educational institution that offers education and research services. The institute provides various programs in the field of art history, languages and literatures, english and creative writing, film and media studies, sociology, psychological and brain sc …
  • High Peak Royalties Limited (HPR)-エネルギー分野:企業M&A・提携分析
    Summary High Peak Royalties Limited (High Peak) is a utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The company has r …
  • Shimano Inc (7309):企業の財務・戦略的SWOT分析
    Shimano Inc (7309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Procurri Corporation Limited (BVQ):企業の財務・戦略的SWOT分析
    Procurri Corporation Limited (BVQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Immunicom Inc-医療機器分野:企業M&A・提携分析
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company with focus on the development of a blood filtering device for the treatment of cancer and autoimmune diseases. The company’s lead program, sTNFR Immunopheresis, is a non-drug based cancer therapy that uses a proprietary immunoads …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Veridian Corporation:企業の戦略的SWOT分析
    Veridian Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nichirei Corporation:企業の戦略・SWOT・財務情報
    Nichirei Corporation - Strategy, SWOT and Corporate Finance Report Summary Nichirei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Foundation Medicine Inc (FMI):企業の財務・戦略的SWOT分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • Gecina SA:企業のM&A・事業提携・投資動向
    Gecina SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gecina SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • ICICI Lombard General Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Lombard General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Lombard General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Kirin Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bank of Nanjing Co., Ltd.:戦略・SWOT・企業財務分析
    Bank of Nanjing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Nanjing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Babcock & Wilcox Enterprises Inc (BW):電力:M&Aディール及び事業提携情報
    Summary Babcock & Wilcox Enterprises, Inc. (Babcock & Wilcox) is a provider of technology-based advanced fossil and renewable power generation and environmental equipment. The company offers a range of biomass-fired boilers products such as supercritical boiler, waste-to-energy boilers, heat recover …
  • H. Lundbeck A/S:企業のM&A・事業提携・投資動向
    H. Lundbeck A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's H. Lundbeck A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆